Neurology

Ketamine treatment for bipolar depression may offer new hope, as new research has revealed its potential as a treatment option in real-world settings to significantly reduce symptoms in patients resistant to traditional therapies.

The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease. This therapy is the first of its kind.

Traumatic brain injury accounts for 30% of all injury-related deaths in the United States, and is a major cause of death and disability in the country.

A promising treatment strategy for glioblastoma has been unveiled in a significant breakthrough that addresses the urgent need for effective therapeutic options.

Findings reveal the effect of the pandemic on mental health in youth, showing a significant increase in depression and anxiety diagnoses during COVID-19.

Preoperative radiotherapy may significantly enhance survival rates for glioblastoma, a particularly aggressive brain cancer.

Cannabis and hallucinogen use among adults continued to reach historic highs in 2023, according to the latest findings from the NIH-supported Monitoring the Future (MTF) survey.

Researchers from the University of Cincinnati, Ohio, suggest that increasing levels of the brain protein amyloid-β 42 may slow cognitive decline in Alzheimer’s disease.